Trauma decreases leucine enkephalin hydrolysis in human plasma

Journal of Pharmacology and Experimental Therapeutics

Volumn 288, Issue 2, 1999, Pages 766-773

  Babst, Reto ^a   Bongiorno, Lucilla ^b   Marini, Mario ^b   Roda, L Giorgio ^b   Spagnoli, Giulio ^a   Urbani, Alessandra ^b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPEPTIDASE; CEFAMANDOLE; DICLOFENAC; LEUCINE ENKEPHALIN; PARACETAMOL; RECOMBINANT GROWTH HORMONE;

AGED; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LOCALIZATION; FEMALE; FEMUR FRACTURE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDROLYSIS; IMMUNE RESPONSE; IMMUNOPATHOLOGY; IMMUNOPHENOTYPING; PHYSICAL STRESS; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; REDUCTION; THIN LAYER CHROMATOGRAPHY; TRAUMATOLOGY;

AGED; AGED, 80 AND OVER; AMINOPEPTIDASES; B-LYMPHOCYTES; BLOOD PROTEINS; ENKEPHALIN, LEUCINE; FEMALE; FEMORAL FRACTURES; HUMANS; HYDROLYSIS; IMMUNITY, CELLULAR; MOLECULAR WEIGHT; T-LYMPHOCYTES; WOUNDS AND INJURIES;

EID: 0033035660     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Ader L, Felten DL and Cohen N, eds (1991) Psychoneuroimmunology. Academic Press, New York.
2. Akil H, Madden J IV, Patrick RL and Barchas JD (1976) Stress-induced increase in endogenous opiate peptides: Concurrent analgesia and its reversal by naloxone, in Opiates and Endogenous Opioid Peptides (Kosterlitz HW ed) pp 63-70, Elsevier, Amsterdam.
3. Amoscato AA, Alexander JW and Babcock GF (1989) Surface aminopeptidase activity of human lymphocytes. J Immunol 142:1245-1252.
4. Babst R, Bongiorno L, Marini M, Marzano M, Spagnoli G, Roda LG and Urbani A (1998) Age-induced increase of leucine enkephalin enzyme degradation in human plasma. Peptides 19:1155-1163.
5. Bayer BM, Gastonguay MR and Hernandez MC (1992) Distinction between the in vitro and in vivo inhibitory effects of morphine on lymphocyte proliferation based on agonist sensitivity and naltrexone reversibility. Immunopharmacology 23:117-124.
6. Bolacchi F, Marini M, Urbani A, Gilardi E and Roda LG (1996) Role of enzymes and inhibitors in leu-enkephalin metabolism in Oryctolagus and human plasma. Neurochem Res 21:881-890.
7. Buzzetti R, McLoughlin L, Lavender PN, Clark LH and Rees LH (1989a) Expression of pro-opiomelanocortin gene and quantification of adrenocorticotropic hormone-like immunoreactivity in human normal peripheral mononuclear cells and lymphoid and myeloid malignancies. J Clin Invest 83:733-737.
8. Buzzetti R, McLoughlin L, Scavo D and Rees LH (1989b) A critical assessment of the interactions between the immune system and the hypothalamo-pituitary-adrenal axis. J Endocrinol 120:183-187.
9. Cannon WB (1935) Stress and strain in homeostasis. Am J Med Sci 189:1-14.
10. Carr DJJ and Serou M (1995) Exogenous and endogenous opioids as biological response modifiers. Immunopharmacology 31:59-71.
11. Chipkin RE and Coffin VL (1991) Analgesic and acute central nervous system side effects of the intravenously administered enkephalinase inhibitor SCH 32615. Pharmacol Biochem Behav 38:21-27.
12. Chukwuocha RU, Reyes E and Tokuda S (1994) The in vivo effect of opioid peptides on the murine immune response. Int J Immunopharmacol 16:205-215.
13. Cupps TR and Fauci AS (1982) Corticosteroid-mediated immunoregulation in man. Immunol Rev 65:133-155.
14. Dhabar FS, Miller AH, Stein M, McEwen BS and Spencer RL (1996) Stress-induced changes in blood leucocyte distribution. J Immunol 157:1638-1664.
15. Folstein MF, Folstein S and McHugh P (1975) Mini Mental State: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-198.
16. Hambrook JM, Morgan BA, Rance MJ and Smith CF (1976) Mode of deactivation of the enkephalins by rat and human plasma and rat brain homogenates. Nature 262:782-783.
17. Heijnen CJ, Kavelaars A and Balheux RE (1991) β-Endorphin: Cytokine and neuropeptide. Immunol Rev 119:41-63.
18. Katoh A, Nabeshima T, Ukai R and Kameyama T (1992) Endorpbins do not affect behavioral stress responses in mice. Peptides 13:737-739.
19. Laudenslager ML, Ryan SM, Drugan RC, Hyson RL and Maier SF (1983) Coping and immunosuppression: Inescapable but not escapable shock suppresses lymphocyte proliferation. Science (Wash DC) 221:568-570.
20. Madden J, Akil H, Patrick RL and Barchas JD (1977) Stress-induced parallel changes in central opioid levels and pain responsiveness in the rat. Nature 265: 358-360.
21. Marini M, Urbani A, Bongiorno L and Roda LG (1992) Hydrolysis and association of leucine enkephalin to lymphomic and erythroleukaemic cell lines. III. Soluble enzymes. Int J Immunopharmacol 14:995-1002.
22. Marini M, Urbani A, Bongiorno L and Roda LG (1997) Interindividual variability of enkephalin-degrading enzymes in human plasma. Peptides 18:741-748.
23. Martinez JL Jr and Weinberger SB (1988) Enkephalin hydrolysis in plasma is highly correlated with escape performance in the rat. Behav Neurosci 102:404-408.
24. Plotnikoff NP, Faith RE, Murgo AJ, Herberman RB and Good RA (1997) Methionine enkephalin: A new cytokine - Human studies. Clin Immunol Immunopathol 82: 93-101.
25. Roda LG, Bongiorno L, Trani E, Urbani A and Marini M (1996) Positive and negative immunomodulation by opioid peptides. Int J Immunopharmacol 18:1-16.
26. Roscetti G, Venturelli F and Roda LG (1988) Enkephalin-binding systems in human plasma. III: Comparative protection of different peptides. Neurochem Res 13:221-224.
27. Sacerdote P, Manfredi B, Bianchi M and Panerai E (1994) Intermittent but not continuous inescapable footshock stress affects immune response and immunocyte beta-endorphin concentrations in the rat. Brain Behav Immunol 8:251-260.
28. Saksida LM, Galea LAM and Kavaliers M (1993) Antinociceptive effects of the enkephalinase inhibitor, SCH 34826, in the snail, Cepaea nemoralis. Peptides 14:763-765.
29. Schoening H and Iversen I (1968) Numerical sorting of self-care status: A study of the Kenny self-care evaluation. Arch Phys Med Rehab 49:221-229.
30. Schulteis G and Martinez JL Jr (1993) Experience-dependent regulation of leuenkephalin hydrolysis in rat plasma. Peptides 14:161-167.
31. Shaker M, Shahabi NA and Sharp BM (1994) Expression of naloxone-resistant β-endorphin binding sites on A20 cells: Effects of concanavalin A and dexamethasone. Immunopharmacology 28:183-192.
32. Shavit Y, Lewis JW, Terman GW, Gale RP and Liebeskind JC (1984) Opioid peptides mediate the suppressive effect of stress on natural killer cell cytotoxicity. Science (Wash DC) 223:188-190.
33. Shavit Y, Terman GW, Martin FC, Lewis JW, Liebeskind JC and Gale RP (1985) Stress, opioid peptides, the immune system, and cancer. J Immunol 135:834s-837s.
34. Shurin MR, Kusnekov A, Hamill E, Kaplan S and Rabin BS (1994) Stress-induced alteration of polymorphonuclear leukocyte function in rat. Brain Behav Immunol 8:163-169.
35. Spagnoli GC, Juretic A, Rosso R, Van Bree J, Harder F and Heberer M (1995) Expression of HLA-DR in granulocytes of polytraumatized patients treated with recombinant human granulocyte macrophage-colony-stimulating factor. Human Immunol 43:45-50.
36. van den Bergh P, Rozing J and Nagelkerken L (1993) Identification of two moieties of β-endorphin with opposing effects on rat T-cell proliferation. Immunology 79: 18-23.
37. Viveros OH, Diliberto EJ, Hazum E and Chang KJ (1979) Opiate like material in the adrenal medulla: Evidence for storage and secretion with catecholamines. Mol Pharmacol 16:1101-1108.
38. Watkins LR and Mayer DJ (1987) Multiple endogenous opiate and non-opiate analgesia systems: Evidence of their existence and clinical implications. Ann NY Acad Sci 467:273-299.
39. Weber RJ and Perth A (1989) The periaqueductal gray matter mediates opiate-induced immunosuppression. Science (Wash DC) 245:188-190.
40. 3H]β-endorphin in rat plasma is increased with chronic stress. Eur J Pharmacol 16:229-236.